- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: anti-PD-L1 monoclonal antibody
Total 103464 results
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingLymphoma | Cervical Cancer | Malignant Mesothelioma | Advanced Solid Tumours | Non-Small-Cell Lung CancerChina
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMelanoma | Metastatic Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Recurrent Metastatic MelanomaUnited States
-
Institute of Oncology LjubljanaUniversity of Ljubljana; Military Medical Academy, Belgrade, SerbiaRecruitingMetastatic Melanoma | Immune Checkpoints Inhibitors | Gastrointestinal Microbiome (Bacterial and Viral) | Exosomal mRNA Expression of PD-L1 and IFNγSlovenia
-
NanoMab Technology (UK) LimitedKing's College London; Guy's and St Thomas' NHS Foundation TrustRecruiting
-
Ludwig Institute for Cancer ResearchBoehringer Ingelheim; MedImmune LLC; PharmaJet, Inc.; CureVac; Cancer Research Institute...CompletedNSCLC | Metastatic Non-small Cell Lung CancerUnited States
-
Kyoto Breast Cancer Research NetworkTerminated
-
AstraZenecaLaboratory Corporation of America; Medidata Solutions; IQVIA RDS Inc.; Calyx; Thermo... and other collaboratorsRecruitingErosive EsophagitisUnited States, Italy, Belgium, Vietnam, Spain, Portugal, Russian Federation, Argentina, Greece, Australia, Lithuania
-
PDC*line Pharma SASActive, not recruitingSafety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLCNon Small Cell Lung CancerBelgium, France, Netherlands, Germany, Poland
-
Sichuan UniversityInnovent Biologics (Suzhou) Co. Ltd.Completed
-
The First Hospital of Jilin UniversityRecruitingPD-L1 Positive Locally Advanced Patients With Resectable Gastric CancerChina
-
Lei LiRecruitingMicrosatellite Instability | Recurrent Cervical Cancer | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
Institute of Cancer Research, United KingdomAstraZenecaRecruitingBreast NeoplasmUnited Kingdom
-
Guangzhou Gloria Biosciences Co., Ltd.CompletedAdvanced Solid TumorsChina
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.Completed
-
Effector TherapeuticsCompleted
-
Elizabeth Buchbinder, MDGenentech, Inc.RecruitingStage IV Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Unresectable Stage III Cutaneous Melanoma | Unresectable Stage IV Cutaneous MelanomaUnited States
-
Ludwig Institute for Cancer ResearchXcovery Holding Company, LLC; Cancer Research Institute, New York City; MedImmune...CompletedCarcinoma | NSCLC | Non-small Cell Lung CancerUnited States
-
Third Military Medical UniversityRecruitingSmall Cell Lung Cancer | Lung Cancer | SCLC, Extensive StageChina
-
ABL Bio, Inc.Recruiting
-
Karolinska University HospitalRecruitingMetastatic Triple-Negative Breast CarcinomaSweden
-
AstraZenecaActive, not recruitingNon-muscle-invasive Bladder CancerFrance, Spain, Belgium, Canada, Poland, Germany, Japan, Russian Federation, United Kingdom, Austria, Australia, Netherlands
-
Guy's and St Thomas' NHS Foundation TrustNanoMab Technology (UK) LimitedRecruitingMelanoma | Non-small Cell Lung CancerUnited Kingdom
-
Kiang Wu HospitalCompleted
-
University of SouthamptonBristol-Myers SquibbActive, not recruiting
-
Peking University Cancer Hospital & InstituteRecruiting
-
Nanjing Leads Biolabs Co.,LtdRecruitingAdvanced Malignant TumorsChina
-
Symphogen A/SCompletedLymphoma | Solid Tumor | Metastatic CancerCanada, United States
-
Agenus Inc.Withdrawn
-
Shirish GadgeelMerck Sharp & Dohme LLCWithdrawnNon Small Cell Lung Cancer | PD-L1 Gene Mutation | Advanced Lung Non-Small Cell Carcinoma
-
Dan ZandbergBristol-Myers SquibbActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
SUNHO(China)BioPharmaceutical CO., Ltd.RecruitingAdvanced Malignant TumorsChina
-
University Hospital, BordeauxCompletedButton Battery PoisoningFrance
-
Klinikum EsslingenRecruitingCarcinoma, Non-Small-Cell LungGermany
-
Fukushima Medical UniversityKanagawa Cancer CenterUnknown
-
First Affiliated Hospital of Harbin Medical UniversityNot yet recruitingSmall-cell Lung Cancer
-
Novartis PharmaceuticalsActive, not recruitingAdvanced Solid Tumors | Triple Negative Breast Cancer | Chordoma and Alveolar Soft Part SarcomaUnited States, Taiwan, Spain, Canada, Singapore, Italy, Japan, Israel, France
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Tongji Hospital; Hunan Cancer... and other collaboratorsRecruitingNasopharyngeal Carcinoma | De-escalation TherapyChina
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedMetastatic Breast CancerFrance, Austria, Belgium, Australia, Italy
-
Genor Biopharma Co., Ltd.RecruitingAlveolar Soft Part SarcomaChina
-
Case Comprehensive Cancer CenterCompletedMetastatic Renal Cell CancerUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UMC UtrechtCompletedEsophageal Cancer, Stage II | Esophageal Cancer Stage IIINetherlands
-
R3 Stem CellR3 Medical ResearchRecruitingLow Back PainUnited States
-
GenmabMerck Sharp & Dohme LLC; BioNTech SERecruitingNon Small Cell Lung Cancer MetastaticUnited States, Spain, Netherlands, Italy, France, United Kingdom, Poland, Germany, Portugal
-
Zhujiang HospitalNot yet recruitingHepatocellular Carcinoma Non-resectable
-
Merck Sharp & Dohme LLCTerminatedNeoplasmUnited States, Canada, Israel
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Anaplastic Thyroid Cancer | Other Solid Tumors | Non-small Sell Lung Cancer (NSCLC)United States, Italy, Spain, Hungary, Taiwan, Germany, Netherlands, France, Norway, Poland, Thailand, Lebanon, Turkey, Canada
-
AstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, Taiwan, India, Mexico, Russian Federation, Turkey, China, Korea, Republic of, Philippines, Hong Kong
-
Academic Thoracic Oncology Medical Investigators...AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingColorectal NeoplasmsUnited States, Argentina, Australia, Canada, China, Denmark, Germany, Israel, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, United Kingdom